DNH: Module 3 - Pain

Sunday, December 1, 2019, 1:00 AM - Wednesday, November 30, 2022, 11:00 PM

Instructions for Participation and Credit:
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board. The University of Oklahoma College of Medicine has waived the registration fee for this online enduring material beginning 12/01/2019 through 11/30/2020.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity.  To successfully earn credit, participants must complete the activity and pre-test online during the valid credit period that is noted on the title page.  To receive CME/CE credit, you must receive a minimum score of 80% on the post-test.

If you have not already completed the first module on the Oklahoma Department of Mental Health and Substance Abuse Services Training Institute website (ODMHSAS) follow these steps:

Training Institute ODMHSAS Login instructions

1. Go to: "https://odmhsas.interactyx.com/login.aspx" Login or click "Sign up here" for a new account
2. Scroll down to locate the course or use the search field
3. Click "start" to begin the Do No Harm: Putting Safer Pain Management into Practice module.
4. Read the professional practice gaps, learning objectives and disclosure report.
5. Study the educational content on the ODMHSAS website and complete the pre-test.
6. Once you have completed each module, to earn credit click on the link provided to the OU CloudCME website.

If you have already completed the first module on the ODMHSAS website follow these instructions:

OU CLOUDCME INSTRUCTIONS

1. Click on the registration button and follow the instructions to either create an account or log in.
2. Complete registration
3. Complete the Post-Test           

4. Click on the yellow My CME button    

5. Click on the Evaluations & Certificates button    

6. Click on the complete the evaluation button for Do No Harm: Putting Safer Pain Management Into Practice - 20e001
7. Click on the yellow My CME button
8. Click on the evaluations & certificates button
9. Click on the download certificate button for Do No Harm: Putting Safer Pain Management Into Practice - 20e001to print certificate 

Description:
From 2007-2013, more than 4,600 Oklahomans died of an unintentional poisoning. Prescription drugs are the most common substances involved in unintentional poisoning deaths in Oklahoma.  In 2013, Oklahoma had the sixth highest unintentional poisoning mortality rate in the nation. Prescription drug overdoses kill nearly two Oklahomans per day. They are now the leading cause of injury death for Oklahomans ages 25-64, according to the Oklahoma State Health Department (OSDH). Do No Harm: Putting Safer Pain Management Guidelines into Practice is an online enduring material that meets the requirement for Oklahoma Senate Bill 1446 – Best Practice For An Act Regulating of Opioid Drugs.

The bill encompasses all opioid prescribing in the state, including opioid prescribing in the workers’ compensation system. The bill asks the Oklahoma Board of Medical Licensure and Supervision to require continuing medical education (CME) for prescribers on opioid abuse and misuse, also restricts initial prescriptions for opioids to a seven day supply.  “The Board shall require that the licensee receive not less than one hour of education in pain management or one hour of education in opioid use or addiction each year preceding an application for renewal of a license, unless the licensee has demonstrated to the satisfaction of the Board that the licensee does not currently hold a valid federal Drug Enforcement Administration registration number.”  The course is divided into six (6) modules: Module 1: Overview; Module 2: Epidemic; Module 3:  Pain; Module 4: Analgesia; Module 5: Patient Engagement; and Module 6: Practice Systems. 

Each module is separate; upon passing the post-test (80%) and completing the evaluation credit will be awarded.

Overall Learning Objectives:
Upon completion of this enduring material, participants will improve their competence and performance by being able to:

1. Describe the role clinicians play in the opioid overdose epidemic
2. Recognize pain to be a biopsychosocial phenomenon with intrinsic brain adaptations
3. Identify modalities for pain management, their mechanisms, and limitations
4. Apply guidelines to safer use of opioids for pain management
5. Complete the annual opioid education required by Oklahoma SB 1446

1. Describe pain as being a complex neurophysiologic and social experience.
2. Differentiate acute from chronic and nociceptive from neuropathic pain.
3. Describe pain as being a complex neurophysiologic and social experience.
4. Define the role for opioid treatment in chronic painful conditions by understanding their neurobiology of analgesia, tolerance, dependence, and development of opioid use disorder.

The University of Oklahoma College of Medicine has waived the registration fee for this online enduring material beginning 12/01/2019 through 11/30/2020.

 

ACCME/AMA PRA Accreditation Statement: 
The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this internet activity enduring material for a maximum of 0.30 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Module 1 – Overview  – 1.00 AMA PRA Category 1 Credits™
Module 2 – Epidemic - .25 AMA PRA Category 1 Credits™
Module 3 – Pain - .25 AMA PRA Category 1 Credits™
Module 4 – Analgesia - .50 AMA PRA Category 1 Credits™
Module 5 – Patient Engagement - .50 AMA PRA Category 1 Credits™
Module 6 – Practice Systems – 1.00 AMA PRA Category 1 Credits™

Successful completion of the post-test(s) is/are required to earn AMA PRA Category 1 Credit^TM. Each module is separate; successful completion is defined as a cumulative score of at least 80% percent correct.  Upon passing the post-test and completing the evaluation credit will be awarded. You have three (3) attempts to pass each test. 

AAPA Accreditation Statement:
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for .25 AAPA Category 1 CME credits. Approval is valid for one year from 12/01/2019. PAs should only claim credit commensurate with the extent of their participation. 

Module 1 – Overview – 1.00 AAPA Category 1 CME credits
Module 2 – Epidemic - .25 AAPA Category 1 CME credits
Module 3 – Pain - .25 AAPA Category 1 CME credits
Module 4 – Analgesia - .50 AAPA Category 1 CME credits
Module 5 – Patient Engagement - .50 AAPA Category 1 CME credits
Module 6 – Practice Systems – 1.00 AAPA Category 1 CME credits

AAPA Post-test portion of the activity must state the following:
Successful completion of the post-test is required to earn AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 80% percent correct. You have three (3) attempts to pass each test.

Oklahoma State Board of Pharmacy (OSBP) Accreditation Statement:

This online enduring material has been approved by the Oklahoma State Board of Pharmacy Continuing Education Committee for 3.50 contact hours. 20190130-OK-0631

Module 1 – Overview – 1.00 OSBP Contact Hours 20190130-OK-0631A
Module 2 – Epidemic - .25 OSBP Contact Hours 20190130-OK-0631B
Module 3 – Pain - .25 OSBP Contact Hours 20190130-OK-0631C
Module 4 – Analgesia - .50 OSBP Contact Hours 20190130-OK-0631D
Module 5 – Patient Engagement - .50 OSBP Contact Hours 20190130-OK-0631E
Module 6 – Practice Systems – 1.00 OSBP Contact Hours 20190130-OK-0631F

Successful completion of the post-test is required. Successful completion is defined as a cumulative score of at least 80% percent correct. 

    

Nursing Pharmacology

This course has been approved for Pharmacology hours by the Oklahoma Board of Nursing for 4.2 contact hours of Category B education (based on 50 minutes per contact hour) for Advanced Practice Nurses.  It is the responsibility of the nurse to assure pharmacology hours apply to their scope of practice.

Module 1 – The Standards – 1.20 pharmacology hours
Module 2 – Epidemic - .30 pharmacology hours
Module 3 – Pain - .30 pharmacology hours
Module 4 – Analgesia - .60 pharmacology hours
Module 5 – Patient Engagement - .60 pharmacology hours
Module 6 – Practice Systems – 1.20 pharmacology hours

Successful completion of the post-test(s) is/are required to earn pharmacology hours. Each module is separate; successful completion is defined as a cumulative score of at least 80% percent correct.  Upon passing the post-test and completing the evaluation credit will be awarded. You have three (3) attempts to pass each test.

Nondiscrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices or procedures. This includes, but is not limited to: admissions, employment, financial aid and educational services. Inquiries regarding non-discrimination policies may be directed to: Bobby J. Mason, Institutional Equity Officer, (405) 325-3546, [email protected], or visit www.ou.edu/eoo.

Accommodation Statement: 
Accommodations are available by contacting Jan Quayle at 405-271-2350, ext. 8 or e-mail to: [email protected] as soon as possible.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Conflict Resolution Statement:
The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable.

Policy on Faculty and Presenters Disclosure: 
It is the policy of the University of Oklahoma, College of Medicine that the faculty and presenters disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).

AMA PRA Category 1 Credits™ (0.25 hours), AAPA Category 1 CME Credit (0.25 hours), Non-Physician Attendance (0.25 hours), OBN Pharmacology Contact Hours (Category B) (0.30 hours), Oklahoma Board of Pharmacy Contact Hours (0.25 hours)

You are not logged in.

Please click the button below to login or create a new account before continuing.

Planning and Authoring Committee Members: 
Steven A. Crawford, M.D., D.A.B.F.M., F.A.A.F.P. Family Medicine, Co-author, Narrator, Course Director
Francis Daniel Duffy, M.D., M.A.C.P. Internal Medicine, Lead Author, Co-Course Director
Shannon D. Ijams, M.P.A.S., P.A.-C. – Family Medicine
Kathryn M. L. Konrad, M.S., R.N.C.-O.B., L.C.C.E., F.A.C.C.E.
James W. Mold, M.D., M.PH., D.A.B.F.M. Family Medicine, Co-author

Expert Review Panel Members:
Jeffery S. Alderman, M.D., M.S., F.A.C.P. – Palliative Care
Dorothy Gourley, D.Ph. – Consultant Pharmacist
Martina J. Jelley, M.D., M.S.P.H., F.A.C.P. – Primary Care Internal Medicine
Andrew J. Kolodny, M.D., M.PH., D.A.B.A.M., D.A.B.P.N. – Psychiatry, Public Health
Michael K. Maxwell, M.D., F.A.C.P. – Primary Care Internal Medicine
Layne E. Subera, D.O., M.A., F.A.C.O.F.P. – Primary Care Family Medicine
Bryan A. VanDoren, M.D., D.A.B.A.M., F.A.S.A.M. – Internal Medicine, Addiction and Pain Medicine
William H. Yarborough, M.D., F.A.C.P.M. – Internal Medicine, Addiction and Pain Medicine

 

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind contribution given by a commercial interest, which is used to pay all or part of the costs of a CME activity. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

This activity received no commercial or in-kind support.

Federal and State Grant Acknowledgements
Oklahoma Department of Mental Health Substance Abuse Services (ODMHSAS)
Oklahoma Primary Healthcare Improvement Cooperative (OPHIC)
Substance Abuse and Mental Health Services Administration (SAMHSA) through the ODMHSAS

These contracts and agreements do not meet the definition of commercial or in-kind support.